Intellia Therapeutics said on Monday its experimental therapy for a rare genetic disorder has met the main goal in a late-stage study. (Reporting by Kunal Das; Editing by Vijay ...
Farmers around the world are facing the second surge in fertiliser prices in four years due to the Iran war. But with grain ...
An employee of Ukraine's Zaporizhzhia nuclear power plant, controlled by Russian forces, was killed in a Ukrainian drone ...
Meta Platforms has signed an agreement with Overview Energy to secure power from the startup's space-based solar energy ...
The Bank of Canada is expected to keep rates on hold at 2.25% on Wednesday as the oil price shock from the Iran war is a ...
The combined deficit of Russian regional budgets will grow by 27% to 1.9 trillion roubles ($25.4 billion) in 2026, largely ...
Domino's Pizza missed same-store sales estimates for the first quarter on Monday, as higher living costs tied to ongoing ...
The fragile demand recovery seen by consumer companies globally is at risk of getting stalled by chances of more prices hikes ...
The bitter legal fight between Elon Musk and the leading artificial intelligence firm, OpenAI, led by Sam Altman, may come ...
The man accused of shooting a U.S. Secret Service agent as he tried to breach security at a Washington dinner where President ...
By Erica Stapleton and Andrew Hay SANTA FE, New Mexico, April 27 (Reuters) - Authorities in New Mexico are trying to ...
Federal Reserve policymakers will gather in Washington this week in what may be Jerome Powell's last meeting as head of the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results